Does US FDA Need An Independent Commission To Analyze Its Pandemic Response?
Group of outside experts could help the agency determine the pandemic-inspired practices and regulatory changes to keep, former commissioner von Eschenbach says.
You may also be interested in...
Stakeholders believe virtual meetings should remain an option going forward, but that in-person sessions should still be convened in many cases.
One of the lessons learned from the pandemic may be that virtual meetings can be used in place of an in-person session more often.
Three of the US FDA’s former leaders believe the agency is coming through COVID with its reputation intact. They still support making the agency independent of the broader Health & Human Services Department, but the urgency may be gone.